Terms: = Bone cancer AND MYH11, ENSG00000133392, 4629 AND Prognosis
18 results:
1. AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.
Assaf N; Lefebvre C; Raggueneau V; Guignedoux G; Marceau-Renaut A; Chevalier S; Tondeur S; Bories D; Benramdane R; Rousselot P; Terré C
Hematology; 2022 Dec; 27(1):636-641. PubMed ID: 35622005
[TBL] [Abstract] [Full Text] [Related]
2. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-myh11 acute myeloid leukemia.
Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
[TBL] [Abstract] [Full Text] [Related]
3. The Identification of Key Gene Expression Signature in Prostate cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract] [Full Text] [Related]
4. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
[TBL] [Abstract] [Full Text] [Related]
5. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract] [Full Text] [Related]
6. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A bone Marrow Pathology Group Multicenter Study.
Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
[TBL] [Abstract] [Full Text] [Related]
7. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract] [Full Text] [Related]
8. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract] [Full Text] [Related]
9. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
[TBL] [Abstract] [Full Text] [Related]
10. Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia.
Kömür M; Erbey F; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(5):1393-5. PubMed ID: 21198299
[TBL] [Abstract] [Full Text] [Related]
11. Detection of a novel CBFB/myh11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.
Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
[TBL] [Abstract] [Full Text] [Related]
12. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
[TBL] [Abstract] [Full Text] [Related]
13. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.
Egan N; O'Reilly J; Chipper L; Higgins M; Herrmann R; Cannell P
Cancer Genet Cytogenet; 2004 Oct; 154(1):60-2. PubMed ID: 15381374
[TBL] [Abstract] [Full Text] [Related]
14. Type J CBFbeta/myh11 transcript in the M4Eo subtype of acute myeloid leukemia.
Trnková Z; Peková S; Bedrlíková R; Záková D; Zemanová Z; Polák J; Michalová K; Cermák J; Schwarz J
Hematology; 2003 Apr; 8(2):115-7. PubMed ID: 12745661
[TBL] [Abstract] [Full Text] [Related]
15. Molecular analysis of a new variant of the CBF beta-myh11 gene fusion.
Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
[TBL] [Abstract] [Full Text] [Related]
16. [The genetic diagnosis of hematopoietic malignancy by polymerase chain reaction method].
Yokota H; Kitamura K
Rinsho Byori; 2000 Aug; 48(8):708-15. PubMed ID: 11064593
[TBL] [Abstract] [Full Text] [Related]
17. A unique structural abnormality of chromosome 16 resulting in a CBF beta-myh11 fusion transcript in a patient with acute myeloid leukemia, FAB M4.
O'Reilly J; Chipper L; Springall F; Herrmann R
Cancer Genet Cytogenet; 2000 Aug; 121(1):52-5. PubMed ID: 10958941
[TBL] [Abstract] [Full Text] [Related]
18. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.
Martinez-Climent JA; Comes AM; Vizcarra E; Reshmi S; Benet I; Marugan I; Tormo M; Terol MJ; Solano C; Arbona C; Prosper F; Barragan E; Bolufer P; Rowley JD; García-Conde J
Cancer Genet Cytogenet; 1999 Apr; 110(2):111-4. PubMed ID: 10214358
[TBL] [Abstract] [Full Text] [Related]
